Evidence suggests that caspase-2 deficiency protects mice from diet-induced obesity, metabolic syndrome, and non-alcoholic fatty liver disease, which has led to speculation that caspase-2 activity in NASH is beyond apoptosis. This evidence concerns the gene CASP2 and obesity due to melanocortin 4 receptor deficiency.